Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Pirarubicin, an Anthracycline Anticancer Agent, Induces Apoptosis Through Generation of Hydrogen Peroxide

HIDEKI MIZUTANI, SAKI HOTTA, AYANO NISHIMOTO, KENJI IKEMURA, DAISUKE MIYAZAWA, YOSHIAKI IKEDA, TOHRU MAEDA, MASAE YOSHIKAWA, YUSUKE HIRAKU and SHOSUKE KAWANISHI
Anticancer Research November 2017, 37 (11) 6063-6069;
HIDEKI MIZUTANI
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mizu{at}kinjo-u.ac.jp kawanisi{at}suzuka-u.ac.jp
SAKI HOTTA
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AYANO NISHIMOTO
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENJI IKEMURA
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
2Department of Pharmacy, Mie University Hospital, Tsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAISUKE MIYAZAWA
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIAKI IKEDA
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOHRU MAEDA
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAE YOSHIKAWA
1College of Pharmacy, Kinjo Gakuin University, Nagoya, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUSUKE HIRAKU
3Department of Environmental and Molecular Medicine, Mie University Graduate School of Medicine, Tsu, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHOSUKE KAWANISHI
4Faculty of Pharmaceutical Sciences, Suzuka University of Medical Science, Suzuka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mizu{at}kinjo-u.ac.jp kawanisi{at}suzuka-u.ac.jp
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: Pirarubicin (THP) has shown equal or superior cytotoxicity compared to doxorubicin. One of the main anticancer actions of doxorubicin is believed to be involved in ROS (reactive oxygen species) generation. Therefore, the anticancer mechanisms of THP may involve ROS generation. The aim of this study was to clarify the mechanisms of THP-induced apoptosis through ROS generation. Materials and Methods: We analyzed the apoptotic events induced by THP in HL-60 cells and HP100 cells, hydrogen peroxide (H2O2)-resistant cells derived from HL-60. Results: The apparent cytotoxicity could be detected at above 0.1 μM in HL-60 cells after 24-h incubation, whereas it was suppressed under these conditions in HP100 cells. In HP100 cells, THP-induced apoptosis, evaluated by DNA ladder formation, H2O2 generation, mitochondrial membrane potential decrease and caspase-3/7 activity, was suppressed or delayed compared to those of HL-60 cells. Conclusion: These findings can be explained by the involvement of H2O2 generation in the THP apoptotic pathway. This is the first report on THP-induced apoptosis through the H2O2 generation.

  • Pirarubicin
  • apoptosis
  • hydrogen peroxide
  • ROS

Anthracyclines are anticancer drugs and are the most important drug categories in clinical usage. Doxorubicin (Figure 1), an anthracycline drug, shows potent effects on solid cancers as well as hematological malignancies (1-3). Pirarubicin (4’-O-tetrahydropyranyl doxorubicin, THP) (Figure 1), a tetrahydropyranyl-derivative doxorubicin, was found and developed by Umezawa et al. in 1979 (4). THP showed equal or superior cytotoxicity in cultured tumor cells, and less cardiotoxicity in hamsters compared to DOX (5, 6). THP is incorporated into cells about 170-times rapider than DOX in cultured tumor cells (5, 7). THP is clinically approved for head and neck cancer, stomach cancer, upper urinary tract cancer, uterus cancer, ovarian cancer, acute leukemia and malignant lymphoma in Japan. Recently, Hori et al. reported that THP appeared to be less cardiotoxic than daunorubicin on acute and late toxicities in the treatment of childhood acute lymphoblastic leukemia on a clinical trial by the Japan Association of Childhood Leukemia Study (8). On the other hand, THP has attracted increasing attention, because THP-DDS (drug delivery systems) developed by Maeda et al. have high tumor-targeting efficiency by EPR (enhanced permeability and retention) effect (9, 10). Maeda and his collaborators were also successful at treating the THP-DDS (HPMA copolymer-conjugated pirarubicin) for a patient with stage IV prostate cancer and extensive lung and bone metastases (11). Therefore, THP has once more attrected attention in the field of cancer chemotherapy.

Anthracyclines generate ROS (reactive oxygen species) causing oxidative DNA damage that may be one of THP anticancer mechanisms (1-3). ROS also play an important role in cell signaling as well as in anticancer mechanisms (12-14), whereas the role of ROS in THP anticancer mechanisms remains to be clarified and is not reported. To clarify THP anticancer mechanisms, we investigated the mechanism of THP-induced apoptosis in HL-60 cells and HP100 cells, hydrogen peroxide (H2O2)-resistant cells derived from HL-60. The mechanism of apoptosis was analyzed by examining cytotoxicity, DNA ladder formation, H2O2 generation, mitochondrial membrane potential (ΔΨm) change and caspase-3/7 activity.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Chemical structure of pirarubicin and doxorubicin.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Detection of cytotoxicity in HL-60 and HP100 cells treated with THP. HL-60 and HP100 cells (0.5×106 cells/ml) were treated with THP at 37°C for 6 h (A) and 24 h (B). After treatment with THP, cytotoxicity was analyzed by the LDH activity assay kit (CytoTox-ONE™ Homogeneous Membrane Integrity Assay, Promega) according to the manufacturer's instructions. The data were expressed as means±SD (n=3). **p<0.01, vs. control by ANOVA followed by Tukey's HSD test; #p<0.05 and ##p<0.01, HL-60 vs. HP100 by the Student's t-test.

Materials and Methods

Materials. Pirarubicin was purchased from Sigma Chemical Co. (St. Louis, MO, USA). Proteinase K was obtained from Merck (Darmstadt, Germany). Fluorescent probes, 2’,7’-Dichlorofluorescin diacetate (DCFH-DA) and 3,3’-dihexyloxacarbocyanine iodide [DiOC6(3)] were purchased from Molecular Probes (Eugene, OR, USA). All other chemicals used were of the highest purity commercially available.

Cell culture and treatment with THP. HP100 cells have been derived from human leukemia HL-60 cells by repeated exposure to H2O2, followed by outgrowth of viable cells. HP100 cells were approximately 340-fold more resistant to H2O2 than HL-60 cells (15). Catalase activity of HP100 cells is 18-times higher than that of HL-60 cells (16). When scavengers such as catalase, superoxide dismutase and reduced glutathione are added in cell culture medium, these scavengers exist in the extracellular environment (17, 18). Therefore, the effects of the scavengers are not evaluated correctly. On the other hand, the increased catalase of HP100 cells exist in the intracellular components, thus the effects of catalase can be evaluated correctly. HL-60 and HP100 cells were grown in RPMI 1640 supplemented with 6% FBS at 37°C under 5% CO2 in a humidified atmosphere. The cells (0.5×106 or 1×106 cells/ml) were then treated with the indicated concentrations of THP.

Determination of cytotoxicity induced by THP in HL-60 and HP100 cells. A lactate dehydrogenase (LDH) activity assay kit (CytoTox-ONE™ Homogeneous Membrane Integrity Assay, Promega, USA) was used to measure cytotoxicity in cultures. 5×104 cells were seeded into each well of 96-well culture plates. After the treatment with THP for 6 or 24 h, cytotoxicity was analyzed according to the manufacturer's instructions (19).

Detection of apoptosis induced by THP in HL-60 and HP100 cells. For analyses of DNA ladder formation after the cells were treated with THP, cells were washed twice with PBS. Cells (2×106 cells), resuspended in 1 ml cytoplasm extraction buffer [10 mM Tris (pH 7.5), 150 mM NaCl, 5 mM MgCl2 and 0.5% Triton X-100], were centrifuged at 1,000 × g for 5 min at 4°C. The pellet was resuspended in lysis buffer [10 mM Tris (pH 7.5), 400 mM NaCl and 1 mM EDTA] and centrifuged at 12,000 × g for 10 min at 4°C. The supernatant was then treated with 0.2 mg/ml RNase overnight at room temperature, followed by treatment with proteinase K as described previously (20). DNA ladder formation was analyzed by conventional electrophoresis.

Imaging cytometric analysis of peroxide generation and ΔΨm change in cells treated with THP. HL-60 and HP100 cells (1×106 cells/ml) were treated with THP at 37°C for the indicated times. After the treatment, the cells were incubated with 5 μM DCFH-DA for 30 min (peroxide generation) or 40 nM DiOC6(3) for 15 min (ΔΨm) at 37°C. Cells were then washed twice with PBS. Following resuspension in PBS, the cells were analyzed on an imaging cytometer (Tali™ Image-based Cytometer; Invitrogen, USA). Dead cells and debris were excluded from the analysis by cell sizes (21).

Caspase-3/7 analysis of apoptosis induced by THP in HL-60 and HP100 cells. A caspase-3/7 activity assay kit (Apo-ONE® Homogeneous Caspase-3/7 Assay, Promega, USA) was used to measure caspase-3/7 activity in cultures. 5.0×104 cells were seeded into each well of 96-well culture plates. After the treatment with THP for 24 h, caspase-3/7 activity was analyzed according to the manufacturer's instructions.

Results

Cytotoxicity in HL-60 and HP100 cells induced by THP. We determined cytotoxicity in the cells treated with THP using an LDH release assay. As observed in Figure 2A and B, HL-60 cells were more sensitive to THP in comparison to HP100 cells at 6-h and 24-h incubation (p<0.05). At 6 h, THP induced significant cytotoxicity at 0.5, 1.0 and 2.0 μM in HL-60 (p<0.01), but not in HP100 cells. The cytotoxicity of THP for 24-h incubation was higher than that of THP for 6-h incubation. The cytotoxicity at 0.1 μM THP for 24-h incubation was about 68% in HL-60 cells, whereas that was only approximately 15% in HP100 cells. Therefore, HL-60 cells were about 4.5-fold sensitive to THP than HP100 cells at 0.1 μM THP for 24-h incubation.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Detection of DNA ladder formation in HL-60 and HP100 cells treated with THP. HL-60 and HP100 cells (0.5×106 cells/ml) were treated with THP at 37°C for 8 h (A), 16 h (B) and 24 h (C). The cells were lysed, and DNA was extracted and analyzed by conventional electrophoresis. Marker lane: size marker DNA (ΦX174/Hae III digest).

DNA ladder formation in HL-60 and HP100 cells treated with THP. We have analyzed DNA ladder formation, which is characteristic for apoptosis, in the cells treated with THP using conventional electrophoresis (Figure 3). The DNA ladder formation by THP could be detected at 0.2 and 0.5 μM in HL-60 and HP100 cells after 8-h incubation (Figure 3A), and it could be detected at 0.1, 0.2 and 0.5 μM in HL-60 and HP100 cells after 24-h incubation (Figure 3C). After 16-h incubation, the DNA ladder by THP could be detected at 0.1, 0.2 and 0.5 μM in HL-60 cells, whereas it could not be detected at 0.1 μM in HP100 cells (Figure 3B). On the other hand, after 6-h incubation, the DNA ladder by THP could not be detected at in both HL-60 and HP100 cells (data not shown).

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Generation of H2O2 in HL-60 and HP100 cells treated with THP. HL-60 and HP100 cells (1×106 cells/ml) were treated with THP at 37°C for 3 h (A) and 6 h (B). After the treatment, the cells were incubated with 5 μM DCFH-DA for 30 min at 37°C. The cells were analyzed with an imaging cytometer (Tali™ Image-based Cytometer; Invitrogen, USA). The data were expressed as means±SD (n=9 capture fields). *p<0.05 and **p<0.01, vs. control by ANOVA followed by Tukey's HSD test; ##p<0.01, HL-60 vs. HP100 by the Student's t-test.

Generation of peroxide and change of ΔΨm in HL-60 and HP100 cells treated with THP. As shown in Figures 4A and B, peroxide generation in HL-60 and HP100 cells was observed at 3 and 6 h. The peroxide generation in HL-60 cells remarkably increased at 3 h after the treatment with THP (p<0.01), whereas its generation in HP100 cells was significantly suppressed at 3 and 6 h compared with HL-60 cells (p<0.01). These results indicate that the THP-induced peroxide is mainly H2O2, because catalase activity in HP100 cells is much higher than that in HL-60 cells (16). Figure 5A and B show change of ΔΨm in HL-60 and HP100 cells treated with THP. ΔΨm was apparently decreased at above 0.05 μM THP in HL-60 and HP100 cells at 16-h incubation (p<0.01), whereas the decrease of ΔΨm in HP100 cells was significantly suppressed in comparison with HL-60 cells at above 0.2 μM THP (p<0.01).

Assessment of THP-induced apoptosis by caspase-3/7 activity in HL-60 and HP100 cells. We assessed THP-induced apoptosis by activation of caspase-3/7. The activation of caspase-3/7 in THP-treated cells was measured using a caspase-3/7 activity assay kit at 24-h incubation. The caspase-3/7 activity was remarkably increased in treatment with THP at above 0.1 μM in HL-60 and HP100 cells (p<0.001). Caspase-3/7 activity in HL-60 was significantly higher than that observed in HP100 at 0.1, 0.2 and 0.5 μM (Figure 6) (p<0.05).

Discussion

The present study showed that THP induced apoptosis in both HL-60 cells and the H2O2-resistant clone, HP100 cells. The apparent cytotoxicity could be detected at above 0.1 μM in HL-60 cells after 24-h incubation, whereas it was suppressed under these conditions in HP100 cells. The apparent DNA ladder formation could be detected at above 0.2 μM after 8-h incubation and at above 0.1 μM after 24-h incubation in HL-60 and HP100 cells, whereas it could be detected at above 0.1 μM in HL-60 cells and at above 0.2 μM in HP100 cells after 16-h incubation. In HP100 cells, assessment of THP-induced apoptosis by peroxide generation, ΔΨm decrease and caspase-3/7 activity were suppressed, compared to those of HL-60 cells. Peroxide formation preceded the apparent cytotoxicity, DNA ladder, caspase-3/7 activation and ΔΨm decrease in THP-induced apoptosis; in HL-60 cells. The peroxide formation occurred at 3 h and 6 h in HL-60 cells, whereas the peroxide formation was suppressed in HP100 cells. It was reported that HP100 cells are about 340-fold more resistant to H2O2 than the parent cells, HL-60 (15). Therefore, these findings can be explained by the involvement of H2O2 generation in the THP apoptotic pathway.

Figure 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 5.

Change of mitochondrial membrane potential (ΔΨm) in HL-60 and HP100 cells treated with THP. HL-60 and HP100 cells (1 x 106 cells/ml) were treated with THP at 37°C for 6 h (A) and 16 h (B). After the treatment, the cells were incubated with 40 nM DiOC6(3) for 15 min at 37°C. The cells were analyzed with an imaging cytometer (Tali™ Image-based Cytometer; Invitrogen, USA). The data were expressed as means±SD (n=9 capture fields). **p<0.01, vs. control by ANOVA followed by Tukey's HSD test; ##p<0.01, HL-60 vs. HP100 by the Student's t-test.

It has been considered that the anticancer mechanisms of anthracyclines are due to DNA intercalation, topoisomerase II inhibition and ROS generation (1-3). The DNA intercalation inhibits DNA and RNA synthesis, and results in double-strand DNA breaks (1-3). The topoisomerase II inhibition results in double-strand DNA breaks, and ROS generated by the redox-cycle of anthracyclines cause oxidative DNA damage (1-3). The main mechanism is considered to be the topoisomerase II inhibition, however it is considered that ROS generation is also an important mechanism. We reported that DOX induced apoptosis through H2O2 generation (22), and also reported that DOX caused site-specific oxidative DNA damage in the presence of copper(II) (23). In addition, many antioxidants attenuate apoptosis and cardiotoxicity induced by anthracyclines (24-28). These reports suggest that H2O2 formation plays important roles in apoptosis induced by anthracyclines. Moreover, mitochondrial dysfunction also induces H2O2 production that induces more DNA damage (29-31). Thus, we conclude that the apoptotic pathways of DNA damage-induced THP are as follows: THP induces oxidative DNA damage through H2O2 generation, DNA cleavage through topoisomerase II inhibition and DNA intercalation. Oxidative DNA damage and DNA cleavage cause mitochondrial dysfunction, inducing cytochrome c release that activates caspase-3/7, leading to apoptosis (Figure 7).

Figure 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 6.

Caspase-3/7 analyses of apoptosis induced by THP in HL-60 and HP100 cells. HL-60 and HP100 cells (0.5×106 cells/ml) were treated with THP at 37°C for 24 h. After treatment with THP, caspase-3/7 was analyzed by the caspase-3/7 activity assay kit (Apo-ONE® Homogeneous Caspase-3/7 Assay, Promega, USA) according to the manufacturer's instructions. The data were expressed as means±SD (n=3). ***p<0.001, vs. control by ANOVA followed by Tukey's HSD test; #p<0.05, ##p<0.01 and ###p<0.001, HL-60 vs. HP100 by the Student's t-test.

Figure 7.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 7.

Proposed mechanisms of THP-induced apoptosis via H2O2 generation.

In conclusion, we demonstrated that H2O2 generation was involved in the THP apoptotic pathway. This H2O2 generation may be a useful clinical biomarker for anticancer activity or cardiotoxicity of THP in comparison to other anthracyclines. This is the first report on THP-induced apoptosis through H2O2 generation.

Acknowledgements

This work was supported by JSPS KAKENHI Grant Number 25460229 and 16K08420.

Footnotes

  • This article is freely accessible online.

  • Received June 23, 2017.
  • Revision received July 18, 2017.
  • Accepted July 19, 2017.
  • Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved

References

  1. ↵
    1. Gewirtz DA
    : A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741, 1999.
    OpenUrlCrossRefPubMed
    1. Minotti G,
    2. Menna P,
    3. Salvatorelli E,
    4. Cairo G,
    5. Gianni L
    : Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol Rev 56: 185-229, 2004.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    1. Meredith AM,
    2. Dass CR
    : Increasing role of the cancer chemotherapeutic doxorubicin in cellular metabolism. J Pharm Pharmacol 68: 729-741, 2016.
    OpenUrl
  3. ↵
    1. Umezawa H,
    2. Takahashi Y,
    3. Kinoshita M,
    4. Naganawa H,
    5. Masuda T,
    6. Ishizuka M,
    7. Tatsuta K,
    8. Takeuchi T
    : Tetrahydropyranyl derivatives of daunomycin and adriamycin. J Antibiot (Tokyo) 32: 1082-1084, 1979.
    OpenUrlPubMed
  4. ↵
    1. Miller AA,
    2. Salewski E
    : Prospects for pirarubicin. Med Pediatr Oncol 22: 261-268, 1994.
    OpenUrlPubMed
  5. ↵
    1. Tsuruo T,
    2. Iida H,
    3. Tsukagoshi S,
    4. Sakurai Y
    : 4’-O-tetrahydropyranyladriamycin as a potential new antitumor agent. Cancer Res 42: 1462-1467, 1982.
    OpenUrlAbstract/FREE Full Text
  6. ↵
    1. Kunimoto S,
    2. Miura K,
    3. Takahashi Y,
    4. Takeuchi T,
    5. Umezawa H
    : Rapid uptake by cultured tumor cells and intracellular behavior of 4’-O-tetrahydropyranyladriamycin. J Antibiot (Tokyo) 36: 312-317, 1983.
    OpenUrlPubMed
  7. ↵
    1. Hori H,
    2. Kudoh T,
    3. Nishimura S,
    4. Oda M,
    5. Yoshida M,
    6. Hara J,
    7. Tawa A,
    8. Usami I,
    9. Tanizawa A,
    10. Yumura-Yagi K,
    11. Kato K,
    12. Kobayashi R,
    13. Komada Y,
    14. Matsuo K,
    15. Horibe K
    : Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study. Int J Clin Oncol 22: 387-396, 2017.
    OpenUrl
  8. ↵
    1. Tsukigawa K,
    2. Liao L,
    3. Nakamura H,
    4. Fang J,
    5. Greish K,
    6. Otagiri M,
    7. Maeda H
    : Synthesis and therapeutic effect of styrene-maleic acid copolymer-conjugated pirarubicin. Cancer Sci 106: 270-278, 2015.
    OpenUrl
  9. ↵
    1. Nakamura H,
    2. Koziolová E,
    3. Chytil P,
    4. Tsukigawa K,
    5. Fang J,
    6. Haratake M,
    7. Ulbrich K,
    8. Etrych T,
    9. Maeda H
    : Pronounced cellular uptake of pirarubicin versus that of other anthracyclines: comparison of HPMA copolymer conjugates of pirarubicin and doxorubicin. Mol Pharm 13: 4106-4115, 2016.
    OpenUrl
  10. ↵
    1. Dozono H,
    2. Yanazume S,
    3. Nakamura H,
    4. Etrych T,
    5. Chytil P,
    6. Ulbrich K,
    7. Fang J,
    8. Arimura T,
    9. Douchi T,
    10. Kobayashi H,
    11. Ikoma M,
    12. Maeda H
    : HPMA copolymer-conjugated pirarubicin in multimodal treatment of a patient with stage IV prostate cancer and extensive lung and bone metastases. Target Oncol 11: 101-106, 2016.
    OpenUrl
  11. ↵
    1. Kalyanaraman B
    : Teaching the basics of redox biology to medical and graduate students: oxidants, antioxidants and disease mechanisms. Redox Biol 1: 244-257, 2013.
    OpenUrlCrossRefPubMed
    1. Redza-Dutordoir M,
    2. Averill-Bates DA
    : Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863: 2977-2992, 2016.
    OpenUrl
  12. ↵
    1. Galadari S,
    2. Rahman A,
    3. Pallichankandy S,
    4. Thayyullathil F
    : Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med 104: 144-164, 2017.
    OpenUrl
  13. ↵
    1. Kasugai I,
    2. Yamada M
    : Adaptation of human leukemia HL-60 cells to hydrogen peroxide as oxidative stress. Leuk Res 13: 757-762, 1989.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Kasugai I,
    2. Yamada M
    : High production of catalase in hydrogen peroxide-resistant human leukemia HL-60 cell lines. Leuk Res 16: 173-179, 1992.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Russell LH Jr.,
    2. Mazzio E,
    3. Badisa RB,
    4. Zhu ZP,
    5. Agharahimi M,
    6. Oriaku ET,
    7. Goodman CB
    : Autoxidation of gallic acid induces ROS-dependent death in human prostate cancer LNCaP cells. Anticancer Res 32: 1595-1602, 2012.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Sakagami H,
    2. Sheng H,
    3. Okudaira N,
    4. Yasui T,
    5. Wakabayashi H,
    6. Jia J,
    7. Natori T,
    8. Suguro-Kitajima M,
    9. Oizumi H,
    10. Oizumi T
    : Prominent Anti-UV Activity and Possible Cosmetic Potential of Lignin-carbohydrate Complex. In Vivo 30: 331-339, 2016.
    OpenUrlAbstract/FREE Full Text
  17. ↵
    1. Mizutani H,
    2. Hiraku Y,
    3. Tada-Oikawa S,
    4. Murata M,
    5. Ikemura K,
    6. Iwamoto T,
    7. Kagawa Y,
    8. Okuda M,
    9. Kawanishi S
    : Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. Cancer Sci 101: 2214-2219, 2010.
    OpenUrlCrossRefPubMed
  18. ↵
    1. Hiraku Y,
    2. Kawanishi S
    : DNA damage and apoptosis induced by benzene metabolites. Cancer Res 56: 5172-5178, 1996.
    OpenUrlAbstract/FREE Full Text
  19. ↵
    1. Lucas BE,
    2. Fields C,
    3. Joshi N,
    4. Hofmann MC
    : Mono-(2-ethylhexyl)-phthalate (MEHP) affects ERK-dependent GDNF signalling in mouse stem-progenitor spermatogonia. Toxicology 299: 10-19, 2012.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Mizutani H,
    2. Tada-Oikawa S,
    3. Hiraku Y,
    4. Kojima M,
    5. Kawanishi S
    : Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxide. Life Sci 76: 1439-1453, 2005.
    OpenUrlCrossRefPubMed
  21. ↵
    1. Mizutani H,
    2. Oikawa S,
    3. Hiraku Y,
    4. Murata M,
    5. Kojima M,
    6. Kawanishi S
    : Distinct mechanisms of site-specific oxidative DNA damage by doxorubicin in the presence of copper(II) and NADPH-cytochrome P450 reductase. Cancer Sci 94: 686-691, 2003.
    OpenUrlCrossRefPubMed
  22. ↵
    1. Granados-Principal S,
    2. Quiles JL,
    3. Ramirez-Tortosa CL,
    4. Sanchez-Rovira P,
    5. Ramirez-Tortosa MC
    : New advances in molecular mechanisms and the prevention of adriamycin toxicity by antioxidant nutrients. Food Chem Toxicol 48: 1425-1438, 2010.
    OpenUrlCrossRefPubMed
    1. Gu J,
    2. Hu W,
    3. Zhang DD
    : Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity. J Cell Mol Med 19: 2324-2328, 2015.
    OpenUrl
    1. Angsutararux P,
    2. Luanpitpong S,
    3. Issaragrisil S
    : Chemotherapy-induced cardiotoxicity: overview of the roles of oxidative stress. Oxid Med Cell Longev 2015: 795602, 2015.
    OpenUrlCrossRefPubMed
    1. Abushouk AI,
    2. Ismail A,
    3. Salem AMA,
    4. Afifi AM,
    5. Abdel-Daim MM
    : Cardioprotective mechanisms of phytochemicals against doxorubicin-induced cardiotoxicity. Biomed Pharmacother 90: 935-946, 2017.
    OpenUrl
  23. ↵
    1. Sordillo PP,
    2. Sordillo DC,
    3. Helson L
    : The prolonged QT interval: role of pro-inflammatory cytokines, reactive oxygen species and the ceramide and sphingosine-1 phosphate pathways. In Vivo 29: 619-636, 2015.
    OpenUrlAbstract/FREE Full Text
  24. ↵
    1. Orrenius S
    : Reactive oxygen species in mitochondria-mediated cell death. Drug Metab Rev 39: 443-455, 2007.
    OpenUrlCrossRefPubMed
    1. Lee K,
    2. Jeong JE,
    3. Kim IH,
    4. Kim KS,
    5. Ju BG
    : Cyclo(phenylalanine-proline) induces DNA damage in mammalian cells via reactive oxygen species. J Cell Mol Med 19: 2851-2864, 2015.
    OpenUrl
  25. ↵
    1. Bagli E,
    2. Goussia A,
    3. Moschos MM,
    4. Agnantis N,
    5. Kitsos G
    : Natural compounds and neuroprotection: mechanisms of action and novel delivery systems. In Vivo 30: 535-547, 2016.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 37, Issue 11
November 2017
  • Table of Contents
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pirarubicin, an Anthracycline Anticancer Agent, Induces Apoptosis Through Generation of Hydrogen Peroxide
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Pirarubicin, an Anthracycline Anticancer Agent, Induces Apoptosis Through Generation of Hydrogen Peroxide
HIDEKI MIZUTANI, SAKI HOTTA, AYANO NISHIMOTO, KENJI IKEMURA, DAISUKE MIYAZAWA, YOSHIAKI IKEDA, TOHRU MAEDA, MASAE YOSHIKAWA, YUSUKE HIRAKU, SHOSUKE KAWANISHI
Anticancer Research Nov 2017, 37 (11) 6063-6069;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Pirarubicin, an Anthracycline Anticancer Agent, Induces Apoptosis Through Generation of Hydrogen Peroxide
HIDEKI MIZUTANI, SAKI HOTTA, AYANO NISHIMOTO, KENJI IKEMURA, DAISUKE MIYAZAWA, YOSHIAKI IKEDA, TOHRU MAEDA, MASAE YOSHIKAWA, YUSUKE HIRAKU, SHOSUKE KAWANISHI
Anticancer Research Nov 2017, 37 (11) 6063-6069;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Oxidative DNA Damage and Apoptosis Induced by Aclarubicin, an Anthracycline: Role of Hydrogen Peroxide and Copper
  • Oxidative DNA Damage Induced by Pirarubicin, an Anthracycline Anticancer Agent, in the Presence of Copper(II)
  • Google Scholar

More in this TOC Section

  • Targeting AURKB Attenuates Tumor Growth in MYC-driven Lung Adenocarcinoma
  • Novel NOTCH1-unmutated T-ALL Cell Line With Suppressed Growth by Gamma-secretase Inhibitors
  • Beneficial Effects of Combining an Immune Checkpoint Inhibitor With Proton Radiation, OXi4503, or Hyperthermia in a Murine Solid Tumor Model
Show more Experimental Studies

Keywords

  • pirarubicin
  • apoptosis
  • Hydrogen peroxide
  • ROS
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire